Table 2.
Provinces and Territories | No. of Patients (%) | IR Benign | IR Malignant | Global Age-Adjusted Incidence (Benign and Malignant CNS Tumors) |
---|---|---|---|---|
Alberta | 308 (9.3) | 1.25 (1.05–1.49) | 1.72 (1.48–1.99) | 2.99 (2.67–3.36) |
British Columbia | 394 (11.9) | 1.77 (1.53–2.04) | 1.97 (1.72–2.26) | 3.78 (3.41–4.19) |
Prince Edward Island | 11 (0.3) | 1.39 (0.58–3.35) | 1.65 (0.74–3.67) | 3.06 (1.70–5.53) |
Manitoba | 123 (3.7) | 1.77 (1.38–2.27) | 1.69 (1.32–2.18) | 3.48 (2.91–4.16) |
New Brunswick | 66 (2.0) | 1.98 (1.42–2.76) | 1.72 (1.21–2.45) | 3.72 (2.92–4.74) |
Nova Scotia | 80 (2.4) | 1.60 (1.15–2.23) | 2.02 (1.51–2.71) | 3.65 (2.92–4.55) |
Ontario | 1438 (43.5) | 1.84 (1.70–1.99) | 2.38 (2.22–2.56) | 4.26 (4.01–4.52) |
Quebec | 717 (21.7) | 1.82 (1.64–2.02) | 1.92 (1.73–2.13) | 3.76 (3.47–4.07) |
Saskatchewan | 108 (3.2) | 1.79 (1.37–2.34) | 1.74 (1.33–2.27) | 3.55 (2.93–4.29) |
Newfoundland and Labrador | 47 (1.4) | 1.94 (1.29–2.91) | 1.99 (1.33–2.97) | 3.95 (2.96–5.26) |
Nunavut/Territoires Nord-Ouest/Yukon | 14 (0.4) | 1.77 (0.84–3.70) | 1.70 (0.81–3.56) | 3.48 (2.06–5.87) |
Total | 3306 (100) | 1.75 (1.66–1.84) | 2.05 (1.94–2.15) | 3.80 (3.65–3.95) |